Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

HANetf ICAV The Medical Cannabis and Wellness UCITS ETF GBP (CBDP)

Sell:623.50p Buy:626.10p 0 Change: 7.25p (1.17%)
Market closed Prices as at close on 22 January 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:623.50p
Buy:626.10p
Change: 7.25p (1.17%)
Market closed Prices as at close on 22 January 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:623.50p
Buy:626.10p
Change: 7.25p (1.17%)
Market closed Prices as at close on 22 January 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
617.55p
Trade high:
630.10p
Year high:
706.50p
Market Listing:
London
Previous close:
617.55p
Trade low:
630.10p
Year low:
398.10p
Size:
$10.95M
Previous:
12.60p (2.00%)
Previous:
12.60p
Volume:
166
Dividend yield:
n/a
Currency:
GBX
Data delayed by at least 15 minutes.

ETP Basics

Issuer: HANetf ICAV
Structure: ETF
Replication method: Stocks - Full Replication
Securities lending: No
Number of holdings: 19
Size: $11M
Launch date: 09 January 2020
Launch price: $7.77
UCITS: Yes
Reporting status: Yes
Domicile: Ireland
Sophisticated product: Non-sophisticated
ISIN: IE00BG5J1M21

Annual & interim reports

Before you invest, please make sure you read the documents below

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents

There are no documents available for this stock.

OBJECTIVE

Index: The Medical Cannabis and Wellness Equity Index is calculated by Solactive AG, and follows a rules-based methodology to measure the performance of an investable universe of publicly listed companies with significant business activities in the legal medical cannabis, hemp and CBD industries. The index methodology embeds a rigorous multi-stage screening process take into account the relevant legal requirements when buying and holding securities in this sector.
Aim: The Fund seeks to track the price and yield performance, before fees and expenses, of...
Read full aim for HANetf ICAV
Leverage: 100%
Currency hedging: No

COSTS

Ongoing Charge (OCF/TER): 0.80%
Management fee: 0.80%
Indicative spread: 0.42%

In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.

Performance

1 week 1W 2.02% 1 year 1Y n/a
1 month 1M 12.59% 2 years 2Y n/a
3 months 3M 7.64% 3 years 3Y n/a
6 months 6M 27.9% 5 years 5Y n/a

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Security Weight
INNOVATIVE INDL PPTYS INC 18.57%
ARENA PHARMACEUTICALS INC 16.47%
SCOTTS MIRACLE-GRO CO 16.00%
GW PHARMACEUTICALS 12.62%
CARA THERAPEUTICS INC 7.63%
GROWGENERATION CORP 7.25%
AMYRIS INC 6.67%
CHARLOTTES WEB HLDGS INC 2.89%
CORBUS PHARMACEUTICALS HLDGS INC 2.08%
MEDICENNA THERAPEUTICS CORP 1.97%
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data provided by Funds Library. Some of the data on this page and other related pages is provided to you for your information and is received from the Fund Management Company administering this fund. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties. Securities lending data correct as at date not available. Charge data correct as at date not available. Holdings correct as at 31 August 2020.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.